Profile
PTHL ABT BSX-PA BSX SYK MDT
Company Name Pheton Holdings Ltd Class A Ordinary Shares Abbott Laboratories Boston Scientific Corporation Boston Scientific Corporation Stryker Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $55.57M $196.03B $175.45B $140.97B $138.31B $109.32B
Employees 0.01K 114.00K 45.00K 48.00K 52.00K 95.00K
CEO Mr. Jianfei Zhang Mr. Robert B. Ford Mr. Michael F. Mahoney Mr. Michael F. Mahoney Mr. Kevin A. Lobo Mr. Geoffrey Straub Martha
Ratings
PTHL ABT BSX-PA BSX SYK MDT
Quant Rating Score 3 2 3 3
Quant Rating Neutral Sell Neutral Neutral
Trading
PTHL ABT BSX-PA BSX SYK MDT
Last Close $3.86 $113.02 $122.18 $95.65 $362.8 $85.25
High 52 $6.44 $120.98 $122.18 $95.95 $392.15 $92.27
Low 52 - $100.07 $122.18 $59.92 $307.75 $76.84
Price vs. 52 Week High -40.06 % -6.58 % 0 % -0.31 % -7.48 % -7.61 %
Price vs. 52 Week Low 0 % 12.94 % 0 % 59.63 % 17.89 % 10.94 %
Total Return
PTHL ABT BSX-PA BSX SYK MDT
1 Month Return -3.5 % -0.32 % 0 % 6.15 % -3.15 % 3.36 %
3 Month Return -28.91 % -2.61 % 0 % 10.23 % 1.06 % -5.11 %
6 Month Return 0 % 9.77 % 0 % 22.6 % 10.42 % 10.6 %
9 Month Return 0 % 3.79 % 0 % 41.83 % 6.98 % 6.26 %
YTD Return -12.47 % -0.08 % 0 % 7.09 % 0.76 % 6.72 %
1 Year Return 0 % -0.79 % 0 % 59.58 % 15.95 % -2.48 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
PTHL ABT BSX-PA BSX SYK MDT
Dividend Yield Percentage (TTM) - 1.46 % - - 0.89 % 3.27 %
Dividend Paid and Capex Coverage Ration (TTM) - 1.45 % 2.95 % 2.95 % 2.09 % 1.35 %
Dividend Per Share (TTM) - 1.65 % - - 3.24 % 2.79 %
Payout Ratio (TTM) - 65.3 % 1.29 % 1.29 % 33.4 % 84.54 %
Profitability
PTHL ABT BSX-PA BSX SYK MDT
Gross Profit Margin TTM 54.7 % 67.3 % 67.3 % 62.47 % 62.65 %
Return on Assets TTM 7.76 % 4.7 % 4.7 % 8.19 % 4.76 %
Return on Equity TTM 14.74 % 8.91 % 8.91 % 18.49 % 8.64 %
Return on Capital Employed TTM 11.6 % 8.57 % 8.57 % 12.38 % 7.56 %
Net Income Per EBT TTM 85.08 % 81.24 % 81.24 % 85.68 % 83.18 %
EBT Per Ebit TTM 98.29 % 79.87 % 79.87 % 93.61 % 87.63 %
EBIT Per Revenue TTM 16.73 % 17.33 % 17.33 % 20.37 % 17.83 %
Cash Flow To Debt Ratio TTM 58.27 % 26.08 % 26.08 % 24.79 % 25.4 %
Receivables Turnover TTM 4.48 6.36 6.36 5.88 5.27
Payables Turnover TTM 4.63 5.74 5.74 6.17 5.19
Inventory Turnover TTM 2.74 1.89 1.89 1.56 2.25
Fixed Asset Turnover TTM 388.07 % 454.83 % 454.83 % 557.01 % 512.52 %
Asset Turnover TTM 55.43 % 41.78 % 41.78 % 50.13 % 36.65 %
Operating Cash Flow Per Share TTM 5.03 1.99 1.99 10.07 5.61
Free Cash Flow Per Share TTM 3.74 1.33 1.33 8.41 4.29
Cash Per Share TTM 449.02 % 169.89 % 169.89 % 1229.07 % 622.97 %
Operating Cash Flow Sales Ratio TTM 21.18 % 18.45 % 18.45 % 17.47 % 21.81 %
Free Cash Flow Operating Cash Flow Ratio TTM 74.31 % 66.93 % 66.93 % 83.49 % 76.43 %
Cash Flow Coverage Ratios TTM 58.27 % 26.08 % 26.08 % 24.79 % 25.4 %
Price To Free Cash Flows Ratio TTM 30.22 72.07 71.74 43.15 19.88
Price To Operating Cash Flows Ratio TTM 22.46 48.2 47.98 36.02 15.19
Price Cash Flow Ratio TTM 22.46 48.2 47.98 36.02 15.19
Income Statement (TTM)
PTHL ABT BSX-PA BSX SYK MDT
Revenue $40.11B $14.24B $14.24B $20.5B $32.36B
Gross Profit $22.13B $9.9B $9.9B $13.1B $21.15B
Gross Profit Ratio 55.18% 69.49% 69.49% 63.89% 65.34%
EBITDA $10.61B $3.45B $3.45B $4.93B $8.2B
Net Income $5.72B $1.59B $1.59B $3.17B $3.68B
EPS Diluted 3.27 1.07 1.07 8.25 2.76
Balance Sheet (MRQ)
PTHL ABT BSX-PA BSX SYK MDT
Long Term Debt $14.55B $8.96B $8.96B $11.26B $24.77B
Total Liabilities $34.39B $15.61B $15.61B $21.32B $39.56B
Total Equity $38.83B $19.53B $19.53B $18.59B $50.42B
Total Investments $1.18B $0.41B $0.41B $0.08B $8.34B
Total Debt $15.87B $9.49B $9.49B $13B $26.05B
Total Assets $73.21B $35.14B $35.14B $39.91B $89.98B
Cash Flow Statement (TTM)
PTHL ABT BSX-PA BSX SYK MDT
Net Income $5.72B $1.59B $1.59B $3.17B $3.68B
Inventory $-0.23B $-0.66B $-0.66B $-0.8B $-0.14B
Dividends Paid $-3.56B $-0.03B $-0.03B $-1.14B $-3.67B
Operating Cash Flow $7.26B $2.5B $2.5B $3.71B $6.79B
Capital Expenditure $-2.2B $-0.8B $-0.8B $-0.58B $-1.59B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 113.02
AEMD Aethlon Medical, Inc. 0.6303
AFIB Acutus Medical, Inc. 0.07
AHCO AdaptHealth Corp. 10.37
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 210.46
ALUR Allurion Technologies Inc. 3.14
AMIX Autonomix Medical, Inc. Common Stock 2.75
ANIK Anika Therapeutics, Inc. 15.58
AORT Artivion, Inc. 29.68
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 1.43
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 11.12
AVNS Avanos Medical, Inc. 15.83
AXDX Accelerate Diagnostics, Inc. 1.08
AXGN AxoGen, Inc. 18.24
AXNX Axonics, Inc. 70.98
AZYO Aziyo Biologics, Inc. 1.49
Unlock